Headlands Technologies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Headlands Technologies's BMY Position: Q4 2025 in Review
Headlands Technologies sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 8,332 shares — an estimated $376K sold.
Headlands Technologies first reported a position in BMY in Q4 2022 and held it in 6 quarters. The position peaked at $4.96M in Q2 2024. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Headlands Technologies reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Headlands Technologies sold 8,332 Bristol-Myers Squibb shares in Q4 2025, an estimated $376K.
- Headlands Technologies first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 6 quarters.
- Headlands Technologies's Bristol-Myers Squibb position peaked at $4.96M in Q2 2024.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Headlands Technologies's 13F filing for Q4 2025, filed 13 Feb 2026.